Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Euronext Paris  >  Ipsen    IPN   FR0010259150

IPSEN (IPN)
Mes dernières consult.
Most popular
  Report  
Real-time Quote. Real-time Tradegate - 06/20 09:59:59 pm
133.775 EUR   -1.38%
04:38pIPSEN : Aujourd’hui, c’est la journée mondiale des quest..
PU
04:08pIPSEN : Today is World Kidney Cancer Q&A Day!
PU
06/13IPSEN : SMC approves Xermelo for carcinoid syndrome diarrhoea
AQ
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets
OFFRE ETE Zonebourse : Jusqu'à 6 mois offerts sur tous les portefeuilles

Ipsen : supports awareness of Neuroendocrine Tumors (NET) and the NET Cancer Day on November 10, 2017

share with twitter share with LinkedIn share with facebook
share via e-mail
0
11/10/2017 | 04:24pm CEST

NET Cancer Day on the 10th of November 2017, is an annual event dedicated to raising awareness of a rare cancer, neuroendocrine tumors (NET).


NET Cancer Day, a global initiative of the International Neuroendocrine Cancer Alliance (INCA) and its members, aims to inform and raise awareness of this often undetected and rare disease amongst the general public and medical institutions with the ultimate goal of providing patients with improved diagnosis and care as they live with NET.
Neuroendocrine tumors: An unusual type of cancer

For more information on NET disease and Cancer Day please visit:
International Neuroendocrine Cancer Alliance
Living with NETs

Livingwithnets.com Website and its contents are intended for an international audience, excluding the United States, Canada and France.

Ipsen SA published this content on 10 November 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 10 November 2017 15:23:04 UTC.

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on IPSEN
04:38pIPSEN : Aujourd’hui, c’est la journée mondiale des questions-réponse..
PU
04:08pIPSEN : Today is World Kidney Cancer Q&A Day!
PU
06/152.5B U.K. fund, Alzheimer`s failure, Alexion-Complement, Targovax tumbles and..
AQ
06/13IPSEN : SMC approves Xermelo for carcinoid syndrome diarrhoea
AQ
06/13IPSEN : Scotlands NHS to fund Ipsen cancer diarrhoea drug
AQ
06/11IPSEN : French pharma company moves HQ from NJ
AQ
06/09IPSEN : moves U.S. headquarters to Kendall Square
AQ
06/06IPSEN : initiates a share buyback program to cover its free share allocation and..
AQ
06/06IPSEN : Green light for Ipsen Biopharm`s new 22m HQ
AQ
06/05GLOBAL PLANT EXTRACTS SOFTWARE MARKE : Indena, Network, Schwabe, Pharmachem, Nat..
AQ
More news
News from SeekingAlpha
05/31YOUR DAILY PHARMA SCOOP : 4 NDAs... CPRX, EXEL, ALPMY, ACOR 
05/29Ipsen in-licenses cancer candidate from MD Anderson 
05/17Cabometyx approved in Europe for first-line kidney cancer; Exelixis up 5% pre.. 
05/16READER INQUIRY : Will Core Biotech Holding Exelixis Rebound? 
04/26Ipsen S.A. reports Q1 results 
Financials (€)
Sales 2018 2 218 M
EBIT 2018 612 M
Net income 2018 414 M
Debt 2018 232 M
Yield 2018 0,82%
P/E ratio 2018 27,43
P/E ratio 2019 22,35
EV / Sales 2018 5,28x
EV / Sales 2019 4,57x
Capitalization 11 482 M
Chart IPSEN
Duration : Period :
Ipsen Technical Analysis Chart | IPN | FR0010259150 | 4-Traders
Technical analysis trends IPSEN
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 14
Average target price 140 €
Spread / Average Target 3,0%
EPS Revisions
Managers
NameTitle
David D. Meek Chief Executive Officer & Director
Marc M. P. de Garidel Non-Executive Chairman
Aymeric Le Chatelier Chief Financial Officer & Executive Vice President
Alexandre P. LeBeaut Chief Scientific Officer
Sotirios G. Stergiopoulos Chief Medical Officer
Sector and Competitors
1st jan.Capitalization (M$)
IPSEN38.34%13 291
JOHNSON & JOHNSON-13.17%325 398
PFIZER-0.17%211 520
NOVARTIS-8.25%188 977
ROCHE HOLDING LTD.-14.38%182 331
MERCK AND COMPANY8.46%164 082